Infant Formula Safety Modernization Act of 2026 updates pathogen and microorganism testing standards for infant formula.
The Infant Formula Safety Modernization Act of 2026 amends the Federal Food, Drug, and Cosmetic Act to enhance safety measures for infant formula. It mandates the Food and Drug Administration to establish clear inspection and compliance standards for all infant formula products, regardless of origin. The bill requires manufacturers to conduct pathogen and microorganism testing in both manufacturing facilities and finished products, including areas designated as Zones 2 and 3.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.